Wolfgang R Oben

Title: Wolfgang R. Oben: Innovator in Pharmaceutical Chemistry

Introduction

Wolfgang R. Oben is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target retroviruses. With a total of 2 patents, his work has implications for the treatment of viral infections.

Latest Patents

Among his latest patents, one is titled "Trifluoromethyl-containing pseudopeptides active against retroviruses." This invention relates to new trifluoromethyl-containing pseudopeptides of a specific general formula, which are designed for use as pharmaceuticals. Another significant patent is for "Substituted (2-oxo-1-benzimidazolinyl)-piperidines," which details processes for their preparation and their application as antiretroviral agents.

Career Highlights

Wolfgang R. Oben is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to focus on innovative solutions in drug development, particularly in combating viral diseases.

Collaborations

Throughout his career, Wolfgang has collaborated with esteemed colleagues, including Dieter H. Abich and Jutta Hansen. These collaborations have fostered a productive environment for research and innovation in pharmaceutical sciences.

Conclusion

Wolfgang R. Oben's contributions to pharmaceutical chemistry, particularly in the development of antiviral agents, highlight his role as a key innovator in the field. His patents reflect a commitment to advancing medical science and improving treatment options for patients.